These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan. Hung KH; Sheu BS; Chang WL; Wu HM; Liu CC; Wu JJ Helicobacter; 2009 Feb; 14(1):61-5. PubMed ID: 19191898 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study. Dzierzanowska-Fangrat K; Rozynek E; Celińska-Cedro D; Jarosz M; Pawłowska J; Szadkowski A; Budzyńska A; Nowak J; Romańczuk W; Prosiecki R; Jóźwiak P; Dzierzanowska D Int J Antimicrob Agents; 2005 Sep; 26(3):230-4. PubMed ID: 16122912 [TBL] [Abstract][Full Text] [Related]
11. The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection. Carothers JJ; Bruce MG; Hennessy TW; Bensler M; Morris JM; Reasonover AL; Hurlburt DA; Parkinson AJ; Coleman JM; McMahon BJ Clin Infect Dis; 2007 Jan; 44(2):e5-8. PubMed ID: 17173210 [TBL] [Abstract][Full Text] [Related]
12. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan. Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862 [TBL] [Abstract][Full Text] [Related]
13. Reality and false premises of antimicrobial susceptibility testing for Helicobacter pylori. Miwa H; Sato N J Gastroenterol; 2003; 38(5):519-21. PubMed ID: 12768400 [No Abstract] [Full Text] [Related]
14. High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. Branca G; Spanu T; Cammarota G; Schito AM; Gasbarrini A; Gasbarrini GB; Fadda G Int J Antimicrob Agents; 2004 Nov; 24(5):433-8. PubMed ID: 15519473 [TBL] [Abstract][Full Text] [Related]
16. Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapy. Kao AW; Cheng HC; Sheu BS; Lin CY; Sheu MJ; Yang HB; Wu JJ J Gen Intern Med; 2005 Feb; 20(2):139-42. PubMed ID: 15836546 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis of Helicobacter pylori infection and determination of clarithromycin resistance by fluorescence in situ hybridization from formalin-fixed, paraffin-embedded gastric biopsy specimens. Can F; Yilmaz Z; Demirbilek M; Bilezikci B; Kunefeci G; Atac FB; Selcuk H; Arslan H; Boyacioglu S; Sahin FI Can J Microbiol; 2005 Jul; 51(7):569-73. PubMed ID: 16175205 [TBL] [Abstract][Full Text] [Related]
18. [Failure in the eradication of Helicobacter pylori: the role of antibiotic resistance]. Lengyel G; Zsolt T Orv Hetil; 2005 May; 146(18):839-42. PubMed ID: 15926629 [TBL] [Abstract][Full Text] [Related]
19. [Resistance to antibiotics used in Helicobacter pylori infection in children]. Maciorkowska E; Kaczmarski M; Kowalczuk J; Kondej-Muszyńska K; Roszko I; Cieśla J; Zielińska A; Musaibili S Pol Merkur Lekarski; 2004 Jun; 16(96):543-6. PubMed ID: 15510893 [TBL] [Abstract][Full Text] [Related]
20. Tn7 distribution in Helicobacter pylori: a selective paradox. Crespo O; Catalano M; Piñeiro S; Matteo M; Leanza A; Centrón D Int J Antimicrob Agents; 2005 Apr; 25(4):341-4. PubMed ID: 15784316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]